Close Menu

docetaxel

A Comparison of Weekly DCF versus Standard DCF as First-line Systemic Chemotherapy for Metastatic Gastric Cancer Patients

DOI: 
10.7727/wimj.2016.536
Synopsis: 
In metastatic gastric cancer (MGC), the goals of treatment are palliation and prolongation of overall survival. Systemic chemotherapy, with docetaxel, cisplatin, infusional 5-fluorouracil (DCF) are a commonly used regimen in MGC as first-line chemotherapy with a low tolerability rate due to its toxicity. We evaluated the efficacy and tolerability of weekly DCF compared to standard DCF regimen.

ABSTRACT

Accepted: 
30 May, 2017
PDF Attachment: 
Journal Sections: 
e-Published: 01 May, 2017

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Clinical Observation of Docetaxel or Gemcitabine Combined with Cisplatin in the Chemotherapy after Surgery for Stage II-III Non-small Cell Lung Cancer

DOI: 
10.7727/wimj.2015.125
Synopsis: 
Chemotherapy is an important part of combined therapy for non-small cell lung cancer and can enhance the survival rate of patients subjected to surgery. This study aimed to compare the efficacy and toxicity of docetaxel combined with cisplatin (DP) and gemcitabine combined with cisplatin (GP) in postoperative chemotherapy after surgery of non-small cell lung cancer NSCLC.

ABSTRACT

Objective: This study aimed to compare the efficacy and toxicity of docetaxel combined with cisplatin (DP) and gemcitabine combined with cisplatin (GP) in postoperative chemotherapy after surgery of non-small cell lung cancer (NSCLC).

Accepted: 
02 Mar, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 18 Nov, 2015

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - docetaxel
Top of Page